Optum guides providers through important upcoming formulary updates
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
December 10, 2019 - Par launched an AB-rated generic version of Novartis’ Afinitor (everolimus) 2.5 mg, 5 mg, and 7.5 mg tablets.
Download PDF
Return to publications
